Categories
SMS Pharmaceuticals Limited — Board Meeting, 22-05-2026: Outcome of Board Meeting
22-05-2026 · 01:50 pm
SMS Pharma's board approved Q4 & FY26 consolidated net profit of ₹32.71 Cr and ₹101.99 Cr. A ₹0.40/share final dividend was proposed. The company also completed ₹47.63 Cr warrant conversions and will shift its registered office within Hyderabad.
No comments yet. Be the first to comment!